3002.15.00/Moderna Spikevax COVID-19 Vaccine/Germany

Moderna Spikevax COVID-19 Vaccine from Germany

Spikevax is an mRNA-based COVID-19 vaccine encoding the SARS-CoV-2 spike protein to elicit immune response. As a biotechnologically produced immunological product in pre-filled syringes for retail sale, it fits HTS 3002.15.00.

Duty Rate — Germany → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Maintain -70°C ultra-cold chain with validated shipping containers and temperature logs

• Submit IND or BLA documentation; declare as finished dosage form

• Beware expiry date issues leading to waste pharma classification under 3006.92

Moderna Spikevax COVID-19 Vaccine from Germany — Import Duty Rate | HTS 3002.15.00